Santa Cruz Biotechnology offers a broad range of BDV Antibodies for the detection and analysis of Bovine Viral Diarrhea Virus (BDV) proteins. BDV Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Bovine Viral Diarrhea Virus is a significant pathogen affecting cattle, leading to substantial economic losses in the livestock industry. BDV causes immunosuppression and can trigger severe reproductive issues in infected animals. Understanding BDV infection mechanisms and their impact on cattle health is essential for developing effective control strategies. Research focusing on BDV proteins helps identify potential therapeutic targets and preventive measures. Investigating viral protein interactions provides insights into disease progression and host immune responses. Advanced research techniques using monoclonal antibodies enable detailed characterization of BDV protein expression patterns. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of BDV and developing solutions for improved animal health.